NIPPON follow-up: Shorter dual antiplatelet therapy stands the test of time (DAPT)

(European Society of Cardiology) Three year follow-up of patients who received dual antiplatelet therapy (DAPT) after placement of a drug-eluting stent (DES) shows that a short course of the therapy continues to be as beneficial as a longer course.